GAMMA DIAGNOSTICS, INC.
GammaCoeur test kit for detecting Gamma Prime Fibrinogen biomarker in blood samples
- Sector
- Medtech
- Headquarters
- 97239, OR
- Latest Form D
- $125K, Jul 2021
- Total capital
- $125K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $125K
- 1 Form D · last Jul 2021
- 63 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$125K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- AJAY H. NAIRExecutive OfficerNamed in SEC Form D filings
- DAVID H. FARRELLExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 5- PendingUse Of Gamma Prime Fibrinogen As A Biomarker In The Assessment Of COVID-19 Infections And Prognosis Of Severe DiseaseUSPTOApplication 18841731
- PendingUse Of Gamma Prime Fibrinogen As A Biomarker In The Assessment For Treatment Of COVID-19 Infections And Long COVID-19USPTOApplication 63439174
- PendingUse Of Y' Fibrinogen As A Biomarker In The Assessment Of COVID-19 Infections And Prognosis Of Severe DiseaseUSPTOApplication PCTUS2022073412
Show all 5 patent records
- Use Of Gamma Prime Fibrinogen As A Biomarker In The Assessment Of COVID-19 Infections And Prognosis Of Severe DiseaseMay 22, 2025 · Application 18841731Pending
- Use Of Gamma Prime Fibrinogen As A Biomarker In The Assessment For Treatment Of COVID-19 Infections And Long COVID-19Application 63439174Pending
- Use Of Y' Fibrinogen As A Biomarker In The Assessment Of COVID-19 Infections And Prognosis Of Severe DiseaseApplication PCTUS2022073412Pending
- Y' Fibrinogen As A Biomarker In The Detection Of COVID-19 And Prognosis Of Severe DiseaseApplication 63268605Pending
- Use Of Gamma Prime Fibrinogen As A Biomarker In The Assessment For Treatment Of COVID-19 Infections And Long COVID-19Application 19148328Pending
Related companies, and why
- Wherible GPS, Inc.Similar federal contract value in Medtech · null in contracts
- SofPulse, Inc.Similar federal contract value in Medtech · null in contracts
- Ineedmd,Inc.Similar federal contract value in Medtech · null in contracts
- StimMed LLCSimilar federal contract value in Medtech · null in contracts
- Retriever Medical, Inc.Similar federal contract value in Medtech · null in contracts
- DIGITALDENTURE PLUS IMPLANTSSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .